We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New Technology Uses Bio-Printed ‘Patches’ to Repair Damaged Heart Tissue

By HospiMedica International staff writers
Posted on 14 Mar 2023
Print article
Image: Personalized ‘bio-inks’ are used to 3D-print cardiac tissues to repair areas of dead tissue caused by heart attacks (Photo courtesy of UTS)
Image: Personalized ‘bio-inks’ are used to 3D-print cardiac tissues to repair areas of dead tissue caused by heart attacks (Photo courtesy of UTS)

Cardiovascular disease remains the leading cause of death globally. One of the associated complications of heart disease is heart failure, in which inadequate blood supply to an affected region causes the death of heart tissue. This often necessitates life-long medication, and end-stage heart failure patients may subsequently be enrolled on a waiting list for a heart transplant. Now, researchers have demonstrated the potential of bio-engineered heart tissues in promoting the safe and effective recovery of patients recovering from damage due to an extensive heart attack.

The cutting-edge technology developed by researchers from The University of Technology Sydney (UTS, Sydney, Australia) fabricates personalized ‘bio-inks’ utilizing stem cells obtained from a patient's body. These "bio-inks" are subsequently utilized for 3D-printing cardiac tissues to repair the regions affected by dead tissues resulting from a heart attack. Further testing for the long-term effects of this technology is underway before it enters clinical trials.

“Our study demonstrated that bio-engineered patches were the best and most robust treatment of heart failure – patches generated with other approaches either did not induce any improvement or the improvement was inconsistent,” said Dr. Carmine Gentile, head of the Cardiovascular Regeneration Group at UTS. “Our bio-engineered patches promise to be safer, more consistent, and cost-effective for the patient. Because this technology will enable patients to use their own stem cells to create the heart ‘patches’, not only can they potentially dramatically reduce the trauma and cost of a heart transplant, but also avoid hurdles such as a body rejecting donor tissues.”

Related Links:
The University of Technology Sydney

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscopy Head Support
Reison 10-330

Print article

Channels

Surgical Techniques

view channel
Image: The tiny, flexible devices can wrap around individual nerve fibers without damaging them (Photo courtesy of 123RF)

Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions

Electric nerve implants serve dual functions: they can either stimulate or block signals in specific nerves. For example, they may alleviate pain by inhibiting pain signals or restore movement in paralyzed... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more